Key facts
- It has raised $4.5M; the latest was Seed Round ($4.5M) in Sep 2025.
- Notable investors include General Catalyst, Diede van Lamoen, SNÖ Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nolla Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Nolla Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nolla Health
Developer of medical diagnostic software designed to facilitate skin condition assessment and early detection from image data. The company's platform is trained on over a million dermatology cases covering more than 1,600 skin conditions, uses vision transformers and multimodal AI models to analyze user-submitted photos, scores image quality, and tracks condition severity over time, enabling individuals concerned about acne, moles, or other skin issues to receive timely, accessible, and medically informed assessments without in-person visits.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2024
- Employees
- 4
- Website
- nollahealth.com/
- Ownership
- Privately Held (backing)
Nolla Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nolla Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nolla Health in its N-PORT filings yet. We sweep new filings monthly.